← Every company
Arcutis Biotherapeutics Inc SEC Filings
What Arcutis Biotherapeutics Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
ARQT overview →Filings on file
94
since Jan 6, 2020
Warning signs
0
none filed
Last results
Aug 5, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Aug 5, 2026 | Executive or director changeResults announced 8-K | Read ↗ |
| Jul 16, 2026 | Executive or director change 8-K | Read ↗ |
| Dec 8, 2025 | Executive or director change 8-K | Read ↗ |
| Apr 10, 2025 | Executive or director change 8-K | Read ↗ |
| Apr 10, 2024 | Executive or director change 8-K | Read ↗ |
| Feb 15, 2024 | Executive or director change 8-K | Read ↗ |
| Sep 27, 2023 | Executive or director change 8-K | Read ↗ |
| Sep 7, 2023 | Executive or director change 8-K/A | Read ↗ |
| Aug 18, 2023 | Executive or director change 8-K | Read ↗ |
| May 24, 2023 | Executive or director change 8-K | Read ↗ |
| Sep 6, 2022 | Executive or director change 8-K | Read ↗ |
| Sep 7, 2021 | Executive or director change 8-K | Read ↗ |
| Jun 14, 2021 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Mar 26, 2021 | Executive or director change 8-K | Read ↗ |
| Nov 4, 2020 | Executive or director change 8-K | Read ↗ |
| Jul 29, 2020 | Executive or director change 8-K | Read ↗ |
| Apr 27, 2020 | Executive or director change 8-K | Read ↗ |
Source: Arcutis Biotherapeutics Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on ARQT
Company overviewEverything on ARQT in one place, with the price.Insider tradingWhat ARQT's own officers and directors buy and sell.Planned salesSales ARQT insiders have filed notice of.Executive payWhat ARQT awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in ARQT.Funds holding itWhich funds and ETFs hold ARQT, and how big a bet.LobbyingWhat ARQT spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on ARQT's account, and who they worked for.PatentsWhat ARQT is filing at the patent office.